000 | 01957 a2200529 4500 | ||
---|---|---|---|
005 | 20250516220704.0 | ||
264 | 0 | _c20150420 | |
008 | 201504s 0 0 eng d | ||
022 | _a1842-1121 | ||
024 | 7 |
_a10.15403/jgld.2014.1121.232.zf1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFekete, Zsolt | |
245 | 0 | 0 |
_aNeoadjuvant conformal chemoradiation with induction chemotherapy for rectal adenocarcinoma. A prospective observational study. _h[electronic resource] |
260 |
_bJournal of gastrointestinal and liver diseases : JGLD _cJun 2014 |
||
300 |
_a171-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdiagnosis |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 |
_aCA-19-9 Antigen _xblood |
650 | 0 | 4 |
_aCarcinoembryonic Antigen _xmetabolism |
650 | 0 | 4 |
_aChemoradiotherapy, Adjuvant _xadverse effects |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInduction Chemotherapy _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoadjuvant Therapy _xadverse effects |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
650 | 0 | 4 | _aOxaliplatin |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aRectal Neoplasms _xdiagnosis |
700 | 1 | _aMuntean, Alina-Simona | |
700 | 1 | _aHica, Ştefan | |
700 | 1 | _aRancea, Alin | |
700 | 1 | _aResiga, Liliana | |
700 | 1 | _aCsutak, Csaba | |
700 | 1 | _aTodor, Nicolae | |
700 | 1 | _aNagy, Viorica Magdalena | |
773 | 0 |
_tJournal of gastrointestinal and liver diseases : JGLD _gvol. 23 _gno. 2 _gp. 171-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.15403/jgld.2014.1121.232.zf1 _zAvailable from publisher's website |
999 |
_c23938077 _d23938077 |